Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pomaglumetad methionine hydrochloride (LY2140023 hydrochloride) is a methionine prodrug of LY404039 with oral activity. LY404039 is a selective mGlu2/3 receptor agonist. Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) has research value in schizophrenia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 212.00 | |
5 mg | In stock | $ 538.00 | |
10 mg | In stock | $ 778.00 | |
25 mg | In stock | $ 1,180.00 | |
50 mg | In stock | $ 1,620.00 |
Description | Pomaglumetad methionine hydrochloride (LY2140023 hydrochloride) is a methionine prodrug of LY404039 with oral activity. LY404039 is a selective mGlu2/3 receptor agonist. Pomaglumetad methionil hydrochloride (LY2140023 hydrochloride) has research value in schizophrenia. |
In vitro | Pomaglumetad methionil (LY2140023) is a high-affinity peptide transporter 1 (PEPT1) substrate with a Km value of ~30 µM. LY2140023 is active against [14C]Gly-Sar with an IC50 value of 0.018 mM[2]. |
In vivo | Pomaglumetad methionil (LY2140023; orally; 3-300 mg/kg; once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) [1]. |
Synonyms | LY2140023 hydrochloride |
Molecular Weight | 402.87 |
Formula | C12H19ClN2O7S2 |
CAS No. | 635318-26-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (55.8 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pomaglumetad methionil hydrochloride 635318-26-2 Neuroscience GluR LY2140023 hydrochloride Pomaglumetad methionil Hydrochloride LY 2140023 Hydrochloride LY2140023 Hydrochloride LY-2140023 Hydrochloride inhibitor inhibit